Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000883354 | SCV001026656 | benign | Dyskeratosis congenita, autosomal recessive 5; Pulmonary fibrosis and/or bone marrow failure, Telomere-related, 3 | 2025-01-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001277142 | SCV002535321 | likely benign | Dyskeratosis congenita | 2020-04-28 | criteria provided, single submitter | curation | |
Gene |
RCV002284449 | SCV002574433 | uncertain significance | not provided | 2022-09-14 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 26109429) |
Ambry Genetics | RCV003169225 | SCV003878513 | likely benign | Inborn genetic diseases | 2023-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV001277142 | SCV001463970 | uncertain significance | Dyskeratosis congenita | 2020-02-13 | no assertion criteria provided | clinical testing |